Preoperative Predictors of Early Recurrence After Liver Resection for Multifocal Hepatocellular Carcinoma

被引:7
作者
Guo, Yuxin [1 ,2 ]
Linn, Yun Le [1 ,2 ,3 ]
Koh, Ye Xin [1 ,2 ,3 ,4 ]
Tan, Ek Khoon [1 ,2 ,3 ,4 ]
Teo, Jin Yao [1 ,2 ,3 ]
Cheow, Peng Chung [1 ,2 ,3 ,4 ]
Jeyaraj, Prema Raj [1 ,2 ,3 ,4 ]
Chow, Pierce K. H. [1 ,2 ,3 ]
Ooi, London L. P. J. [1 ,2 ,3 ]
Chung, Alexander Y. F. [1 ,2 ,3 ,4 ]
Chan, Chung Yip [1 ,2 ,3 ,4 ]
Goh, Brian K. P. [1 ,2 ,3 ,4 ]
机构
[1] Singapore Gen Hosp, Acad, Dept Hepatopancreatobiliary & Transplant Surg, 20 Coll Rd, Singapore 169856, Singapore
[2] Natl Canc Ctr Singapore, Acad, 20 Coll Rd, Singapore 169856, Singapore
[3] Duke Natl Univ Singapore Med Sch, Singapore, Singapore
[4] SingHealth Duke Natl Univ Singapore Transplant Ctr, Liver Transplant Serv, Singapore, Singapore
关键词
Hepatocellular carcinoma; Liver resection; Futile; Early recurrence; Multifocal; TO-LYMPHOCYTE RATIO; PROGNOSTIC NUTRITIONAL INDEX; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; HEPATITIS-B; MILAN CRITERIA; RISK-FACTORS; SURVIVAL; OUTCOMES; TRANSPLANTATION; INTERMEDIATE;
D O I
10.1007/s11605-023-05592-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Liver transplantation remains the optimal treatment for multifocal hepatocellular carcinoma (HCC). However, due to resource constrains, other therapeutic modalities such as liver resection (LR), are frequently utilized. LR, however, has to be balanced against potential morbidity and mortality along with the risks of early recurrence leading to futile surgery. In this study, we evaluated preoperative factors, including inflammatory indices, in predicting early (< 1 year) recurrence in patients who underwent LR for multifocal HCC. Methods This was a post hoc analysis of 250 consecutive patients with multifocal HCC who underwent LR. Results After exclusion of 10 patients with 30-day/in-hospital mortality, 240 were included of which 134 (55.8%) developed early recurrence. Hepatitis B/C aetiology, 3/ > more hepatic nodules and elevated alpha-fetoprotein (AFP) >= 200 ng/ml were significant independent preoperative predictors of early recurrence. The early recurrence rate was 72.1% when 2 out of 3 significant predictive factors were present. The conglomerate of all 3 factors predicted early recurrence of 100% with a statistically significant association between number of predictive factors and early recurrence (p < 0.001). Conclusion Better patient selection via the use of preoperative predictive factors of early recurrence such as hepatitis B/C aetiology, >= 3 nodules and elevated AFP >= 200 ng/ml may assist in identifying patients in whom LR is deemed futile and improve resource allocation.
引用
收藏
页码:1106 / 1112
页数:7
相关论文
共 51 条
[1]  
[Anonymous], 2015, J HEMATOLOGY THROMBO
[2]   Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) [J].
Bréchot, C ;
Gozuacik, D ;
Murakami, Y ;
Paterlini-Bréchot, P .
SEMINARS IN CANCER BIOLOGY, 2000, 10 (03) :211-231
[3]   Predictors and patterns of recurrence after resection of hepatocellular carcinoma [J].
Cha, C ;
Fong, YM ;
Jarnagin, WR ;
Blumgart, LH ;
DeMatteo, RP .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (05) :753-758
[4]   Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection [J].
Chan, Anthony W. H. ;
Chan, Stephen L. ;
Wong, Grace L. H. ;
Wong, Vincent W. S. ;
Chong, Charing C. N. ;
Lai, Paul B. S. ;
Chan, Henry L. Y. ;
To, Ka-Fai .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (13) :4138-4148
[5]   Comparison of hepatocellular carcinoma in Eastern versus Western populations [J].
Choo, Su Pin ;
Tan, Wan Ling ;
Goh, Brian K. P. ;
Tai, Wai Meng ;
Zhu, Andrew X. .
CANCER, 2016, 122 (22) :3430-3446
[6]   EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (vol 69, pg 182, 2018) [J].
Galle, Peter R. ;
Forner, Alejandro ;
Llovet, Josep M. ;
Mazzaferro, Vincenzo ;
Piscaglia, Fabio ;
Raoul, Jean-Luc ;
Schirmacher, Peter ;
Vilgrain, Valerie .
JOURNAL OF HEPATOLOGY, 2019, 70 (04) :817-817
[7]   Surgical treatment of hepatocellular carcinoma beyond milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation [J].
Facciuto, Marcelo E. ;
Koneru, Baburao ;
Rocca, Juan P. ;
Wolf, David C. ;
Kim-Schluger, Leona ;
Visintainer, Paul ;
Klein, Kenneth M. ;
Chun, Hoo ;
Marvin, Michael ;
Rozenblit, Grigory ;
Rodriguez-Davalos, Manuel ;
Sheiner, Patricia A. .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (05) :1383-1391
[8]   Liver Resection for Multiple Hepatocellular Carcinomas A Japanese Nationwide Survey [J].
Fukami, Yasuyuki ;
Kaneoka, Yuji ;
Maeda, Atsuyuki ;
Kumada, Takashi ;
Tanaka, Junko ;
Akita, Tomoyuki ;
Kubo, Shoji ;
Izumi, Namiki ;
Kadoya, Masumi ;
Sakamoto, Michiie ;
Nakashima, Osamu ;
Matsuyama, Yutaka ;
Kokudo, Takashi ;
Hasegawa, Kiyoshi ;
Yamashita, Tatsuya ;
Kashiwabara, Kosuke ;
Takayama, Tadatoshi ;
Kokudo, Norihiro ;
Kudo, Masatoshi .
ANNALS OF SURGERY, 2020, 272 (01) :145-154
[9]   Biology and significance of alpha-fetoprotein in hepatocellular carcinoma [J].
Galle, Peter R. ;
Foerster, Friedrich ;
Kudo, Masatoshi ;
Chan, Stephen L. ;
Llovet, Josep M. ;
Qin, Shukui ;
Schelman, William R. ;
Chintharlapalli, Sudhakar ;
Abada, Paolo B. ;
Sherman, Morris ;
Zhu, Andrew X. .
LIVER INTERNATIONAL, 2019, 39 (12) :2214-2229
[10]   The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review [J].
Glantzounis, G. K. ;
Paliouras, A. ;
Stylianidi, M. C. ;
Milionis, H. ;
Tzimas, P. ;
Roukos, D. ;
Pentheroudakis, G. ;
Felekouras, E. .
EJSO, 2018, 44 (02) :195-208